Endogenous BiP Tagging for Protein Misfolding Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods lack an effective and unbiased approach to analyze protein misfolding in the endoplasmic reticulum (ER) due to the absence of conformation-specific antibodies for endogenous proteins, limiting the understanding of protein misfolding in disease progression and ER stress responses.

Innovation Solution

The introduction of a 3xFLAG epitope tag into the endogenous BiP/GRP78/Hspa5 locus via homologous recombination allows for direct analysis of the BiP interactome and protein folding/misfolding in vivo, enabling the identification of unfolded and misfolded proteins and their interactions with BiP.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conformation-specific antibodies are used to analyze protein misfolding, then measurement precision is improved, but the approach is limited by the absence of such antibodies for endogenous proteins

Engineering Contradiction:
Improveprotein misfolding analysisVSAvoidapplicability to endogenous proteins
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The patent introduces an epitope tag as an intermediary element that can be specifically recognized by antibodies. Instead of relying on conformation-specific antibodies for endogenous proteins, the epitope tag serves as a mediator that enables specific detection and analysis of BiP and its interactions, thereby resolving the limitation of antibody availability while maintaining measurement precision

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent creates a tagged version (BiP-3xFLAG) of the endogenous BiP protein, effectively making a copy with added detectable features. This tagged copy allows for specific antibody recognition and analysis without requiring conformation-specific antibodies for the original endogenous protein, thus improving both measurement precision and adaptability

Inventive Principle:
Principle #26Copying

2Measurement precision

If epitope tagging is introduced into the endogenous BiP locus, then analysis capability is improved, but device complexity increases

Engineering Contradiction:
ImproveBiP interactome analysisVSAvoidgenetic modification system
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent performs preliminary genetic modification by introducing the epitope tag into the endogenous BiP locus before conducting interactome analysis. This preliminary action of epitope tagging establishes the foundation for subsequent high-precision analysis, allowing researchers to directly analyze BiP interactions without requiring complex experimental workarounds

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The epitope tag acts as an intermediary that simplifies the analysis system. By providing a specific recognition site for antibodies, the tag reduces the complexity of detecting and analyzing BiP interactions, enabling straightforward immunoprecipitation and mass spectrometry workflows

Inventive Principle:
Principle #24Intermediary (Mediator)

3Manufacturing precision

If homologous recombination is used to introduce epitope tag, then manufacturing precision is improved, but ease of manufacture decreases

Engineering Contradiction:
Improveepitope tag insertion accuracyVSAvoidtransgenic animal production
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent performs preliminary tagging of BiP in transgenic animals through homologous recombination. This preliminary genetic modification ensures precise insertion of the epitope tag at the correct locus, which simplifies subsequent analysis by eliminating the need for complex validation and characterization steps that would otherwise be required

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent creates transgenic animal models with tagged BiP, effectively making a biological copy with modified features. While the initial production is complex, this copied model can be propagated and used for repeated experiments, improving ease of manufacture for subsequent studies

Inventive Principle:
Principle #26Copying

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach provides a novel model for studying BiP interactions under physiological and pathophysiological conditions, enabling the characterization of protein misfolding and ER processes without altering BiP expression or localization, and facilitating the identification of misfolded proteins and their impact on ER function.

Implementation Method 1

The introduction of a 3xFLAG epitope tag into the endogenous BiP/GRP78/Hspa5 locus via homologous recombination allows for direct analysis of the BiP interactome

Methodology Applied
Scientific EffectAntigen-antibody binding:

Data Source

PatentUS20230039930A1Methods and compositions for binding immunoglobulin protein targeting
Publication Date: 2023.02.09 SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
  • US20230039930A1 patent drawing
  • US20230039930A1 patent drawing
  • US20230039930A1 patent drawing

AI summary

Models and methods related to targeting binding immunoglobulin protein (BiP) are described, where the models and methods allow identification and analysis of protein folding and misfolding.